A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. (25th November 2014)

• Record Type: Journal Article
• Authors: Kim, Dong‐Hyun; Xiao, Zhen; Kwon, Sanghoon; Sun, Xiaoxiao; Ryerson, Daniel; Tkac, David; Ma, Ping; Wu, Shwu‐Yuan; Chiang, Cheng‐Ming; Zhou, Edward; Xu, H Eric; Palvimo, Jorma J; Chen, Lin‐Feng; Kemper, Byron; Kemper, Jongsook Kim
• Is Part Of: EMBO journal. Volume 34:Number 2(2015)
• Page Start: 184
• Page End: 199
• Publication Date: 2014-11-25
• Subjects: Molecular biology -- Periodicals; 572.805
• DOI: 10.15252/embj.201489527
• Languages: English
• ISSNs: 0261-4189

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="embj201489527-abs-0003"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Elevated acetylation of the mouse nuclear Farnesoid X receptor (FXR) in obesity inhibits its SUMOylation, which promotes hepatic inflammation and metabolic dysfunction <italic>in vivo</italic>.<boxed-text content-type="graphic" id="embj201489527-blkfxd-0002" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgh31wfmt0d" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>